Székely J I, Dunai-Kovács Z, Miglécz E, Rónai A Z, Bajusz S
J Pharmacol Exp Ther. 1978 Dec;207(3):878-83.
The in vivo equivalent of pA2 values were determined in rat tail-flick and mouse hot-plate tests for naloxone against morphine, beta-endorphin and a synthetic enkephalin analog, (D-Met2,Pro5)-enkephalinamide, as analgesics. In mice the apparent pA2 value of naloxone against morphine (6.86) was similar to that found by previously and essentially the same values were obtained against the opioid peptides, indicating homogenous receptor population for the analgesics studied. In rats the pA2 of naloxone against morphine (7.17) was lower than against either beta-endorphin (7.55) or (D-Met2,Pro5)-enkephalinamide (7.51), warning that in rats such a homogeneity of the "analgesic" receptor population as was observed for mice may not exist.
在大鼠甩尾试验和小鼠热板试验中,测定了纳洛酮对吗啡、β-内啡肽和一种合成脑啡肽类似物(D-蛋氨酸²,脯氨酸⁵)-脑啡肽酰胺作为镇痛药时的体内等效pA2值。在小鼠中,纳洛酮对吗啡的表观pA2值(6.86)与先前发现的值相似,并且对阿片肽获得了基本相同的值,表明所研究的镇痛药具有同质受体群体。在大鼠中,纳洛酮对吗啡的pA2值(7.17)低于对β-内啡肽(7.55)或(D-蛋氨酸²,脯氨酸⁵)-脑啡肽酰胺(7.51)的pA2值,这警示在大鼠中可能不存在如在小鼠中观察到的“镇痛”受体群体的这种同质性。